361 related articles for article (PubMed ID: 16788320)
41. Plasminogen activation and lysis of blood clots induced by cells in vitro.
Knox P; Crooks S
J Cell Physiol; 1988 Jun; 135(3):467-73. PubMed ID: 2456288
[TBL] [Abstract][Full Text] [Related]
42. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
Nielsen VG
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
[TBL] [Abstract][Full Text] [Related]
43. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
Varin R; Mirshahi S; Mirshahi P; Kierzek G; Sebaoun D; Mishal Z; Vannier JP; Yvonne Borg J; Simoneau G; Soria C; Soria J
Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767
[TBL] [Abstract][Full Text] [Related]
44. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
45. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
46. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation.
Duboscq C; Genoud V; Parborell MF; Kordich LC
Thromb Res; 1997 Jun; 86(6):505-13. PubMed ID: 9219330
[TBL] [Abstract][Full Text] [Related]
47. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
48. Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran).
Mattsson C; Björkman JA; Abrahamsson T; Nerme V; Schatteman K; Leurs J; Scharpé S; Hendriks D
Thromb Haemost; 2002 Apr; 87(4):557-62. PubMed ID: 12008935
[TBL] [Abstract][Full Text] [Related]
49. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
Nielsen VG; Cohen BM; Cohen E
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
[TBL] [Abstract][Full Text] [Related]
51. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
[TBL] [Abstract][Full Text] [Related]
52. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Dupe RJ; English PD; Smith RA; Green J
Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
[TBL] [Abstract][Full Text] [Related]
53. Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro.
Martin U; Sponer G; Strein K
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):235-42. PubMed ID: 8388740
[TBL] [Abstract][Full Text] [Related]
54. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.
Weitz JI
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):19S-23S. PubMed ID: 8770837
[TBL] [Abstract][Full Text] [Related]
55. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Kostka B; Para J; Sikora J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
[TBL] [Abstract][Full Text] [Related]
56. Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro.
Zamarron C; Lijnen HR; Collen D
Thromb Res; 1984 Aug; 35(3):335-45. PubMed ID: 6431630
[TBL] [Abstract][Full Text] [Related]
57. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro.
Devcic-Kuhar B; Pfaffenberger S; Gherardini L; Mayer C; Gröschl M; Kaun C; Benes E; Tschachler E; Huber K; Maurer G; Wojta J; Gottsauner-Wolf M
Thromb Haemost; 2004 Nov; 92(5):980-5. PubMed ID: 15543323
[TBL] [Abstract][Full Text] [Related]
58. The tissue-type plasminogen activator story.
Collen D; Lijnen HR
Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
[TBL] [Abstract][Full Text] [Related]
59. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
60. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
